Need professional-grade analysis? Visit stockanalysis.com
$2.06B
22.10
368
N/A
Shanghai HeartCare Med Tech (6609) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD57.95, up 3.02% from the previous close.
Over the past year, 6609 has traded between a low of HKD26.80 and a high of HKD70.50. The stock has gained 107.3% over this period. It is currently 17.8% below its 52-week high.
Shanghai HeartCare Med Tech has a market capitalization of $2.06B, with a price-to-earnings ratio of 22.10.
Shanghai HeartCare Medical Technology Corporation Limited engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. It offers ischemic stroke thrombectomy devices, such as Captor Thrombectomy Stent, a thrombectomy stent retriever; aspiration catheter and pump; intracranial stenosis treatment devices, including intracranial drug-eluting balloon stent, embolization protection system, carotid artery stent, and intracranial balloon dilatation catheter and carotid artery balloon dilatation catheter; hemorrhagic stroke treatment devices, including vascular reconstruction device and flow diverter device; and ischemic stroke prevention devices comprising LAA occlude. The company also provides vascular access devices consisting of distal access catheter, microcatheter, balloon guiding catheter, vascular closure device, support catheter, neuro-interventional microcatheter, neuro-interventional micro guidewire, microcatheter for coiling, microcatheter for flow diverter device, and navigation catheter. Its products are used for acute ischemic stroke and neurovascular stenosis treatment, hemorrhagic stroke treatment, ischemic stroke prevention, and interventional access. The company was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.